: Bivalirudin [Mass/volume] in Platelet poor plasma by Liquid chromatography tandem mass spectrometry (LC-MS/MS) — qualitative or quantitative result as reported
: This test measures the level of bivalirudin, an anticoagulant (blood thinner), in platelet-poor plasma using liquid chromatography with mass spectrometry.
[": It helps your care team confirm how much bivalirudin is present in your blood so therapy can be monitored safely."]
Key facts at a glance
- LOINC
- 73502-7
- Short code
- Bivalirudin ind plt IgM SerPl Ql FC
- Synonyms
- Bivalirudin ind plt IgM SerPl Ql FC
- Category
- hematology
- Sample
- serum
- Container
- Red-top tube (SST)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- flow-cytometry
- CPT
- 82784
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
: What Is Bivalirudin?
: Bivalirudin is a short-acting injectable anticoagulant used during certain heart procedures and in some patients who cannot receive heparin. It works by directly blocking thrombin, an enzyme needed for blood to clot.
: Why This Test Is Ordered
: Your clinician may order this test to check the concentration of bivalirudin in your blood, especially if you have kidney problems, are on higher doses, or are at increased risk of bleeding or clotting. It can help guide dosing decisions.
: How the Sample Is Collected
: A blood sample is drawn into a tube containing an anticoagulant and then processed to separate platelet-poor plasma. The plasma is analyzed in the laboratory by liquid chromatography combined with mass spectrometry, a highly specific method for identifying and measuring drugs.
: What the Results Mean
: Results are reported as the amount of bivalirudin detected in your plasma. Your care team interprets the result together with your dose, timing of the last dose, kidney function, and clinical condition. Results outside the expected therapeutic window may prompt a dose adjustment or closer monitoring.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
: Bivalirudin monitoring can help balance the risk of bleeding against the risk of clot formation, particularly in patients with impaired kidney clearance or those undergoing procedures requiring precise anticoagulation. Because interpretation depends on timing and clinical context, results should always be reviewed by the ordering clinician.
Short name
: Bivalirudin, platelet-poor plasma
Frequently asked questions
: Do I need to fast before this test?
: Can I take my other medications before the blood draw?
: How long does it take to get results?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy